On ECHEMI
Home > Drugs > Nanjing Hicin Pharmaceutical Co., Ltd.
Nanjing Hicin Pharmaceutical Co., Ltd.
  • Founded in:

    2003-01-15
  • Country:

    China China
  • Address:

    No. 1 Hengfa Road, Nanjing Economic and Technological Development Zone
  • Tax NO.:

    913201927453675877
  • Registered Funds:

    120 million yuan
  • Website:

  • Email:

Related Drugs
Mizoribine
Name Description Content CAS NO. Registered Holders
Mizoribine

Extract from the above information

More

Extract from the above information

50924-49-7 3
Nevirapine
Name Description Content CAS NO. Registered Holders
Nevirapine

Extract from the above information

More

Extract from the above information

129618-40-2 20
Voglibose Tablets
The main ingredient of this product is voglibose, and its chemical name is ()-1L-[1(OH),2,4,5/3]-5-[2-hydroxy-1-(hydroxymethyl)ethyl]amino-1-carbon-(hydroxymethyl)-1,2,3,4-cyclohexylfuran. Molecular formula: C10H21NO7, molecular weight: 267.28.
Name Description Content CAS NO. Registered Holders
Voglibose

Inhibit the activity of α-glucosidase in the intestinal wall cells, delay the degradation of ingested carbohydrates, and thus reduce postprandial blood sugar levels

More

Inhibit the activity of α-glucosidase in the intestinal wall cells, delay the degradation of ingested carbohydrates, and thus reduce postprandial blood sugar levels

83480-29-9 11
Adenosine monophosphate
Name Description Content CAS NO. Registered Holders
Vidarabine monophosphate

Extract from the above information

More

Extract from the above information

29984-33-6 12
Levofloxacin Mesylate for Injection
The main ingredients of this product are: Levofloxacin mesylate
Name Description Content CAS NO. Registered Holders
Levofloxacin mesylate

It achieves antibacterial effect by inhibiting the activity of bacterial DNA gyrase (bacterial topoisomerase II) and hindering the replication of bacterial DNA. It has good antibacterial effect on most Enterobacteriaceae, Gram-negative bacteria, some Gram-positive bacteria, Legionella, Mycoplasma, Chlamydia, but has poor effect on anaerobic bacteria and enterococci.

More

It achieves antibacterial effect by inhibiting the activity of bacterial DNA gyrase (bacterial topoisomerase II) and hindering the replication of bacterial DNA. It has good antibacterial effect on most Enterobacteriaceae, Gram-negative bacteria, some Gram-positive bacteria, Legionella, Mycoplasma, Chlamydia, but has poor effect on anaerobic bacteria and enterococci.

226578-51-4 23
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.